The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?

Author: HoWing L, WongHilda, YauThomas

Paper Details 
Original Abstract of the Article :
Recently, there has been an increase in the use of targeted therapies for cancer treatments. Nevertheless, the ocular side-effects of the commonly used targeted agents are generally under-reported and not well studied in the literature. We conducted multiple searches in databases, including Medline,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1755-3768.2012.02518.x

データ提供:米国国立医学図書館(NLM)

Ophthalmological Complications of Targeted Agents in Cancer Therapy

Targeted therapies in cancer treatment, like a caravan searching for a hidden oasis, offer hope for patients. However, these therapies can sometimes have unforeseen side effects. This review focuses on the ophthalmological complications associated with various targeted agents, exploring their impact on the delicate and intricate world of the eye. The authors reviewed numerous studies, highlighting the importance of being aware of these potential side effects.

Navigating the Ocular Landscape of Targeted Therapies

The review found that various targeted agents can cause a range of ocular side effects, affecting different parts of the eye. This research, like a skilled navigator charting the treacherous waters of the ocular system, helps us understand the potential risks associated with these therapies.

The Importance of Ophthalmological Surveillance

This review emphasizes the importance of ophthalmological surveillance in patients receiving targeted therapies. It's like a watchful desert sentinel, keeping a vigilant eye out for potential complications.

Dr.Camel's Conclusion

This review underscores the importance of vigilance and collaboration between oncologists and ophthalmologists, reminding us that even in the most promising of therapies, there can be unexpected side effects.

Date :
  1. Date Completed 2014-04-23
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

22970709

DOI: Digital Object Identifier

10.1111/j.1755-3768.2012.02518.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.